Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibroblast growth factor 21 night watch: advances and uncertainties in the field
Alexei Kharitonenkov, Richard D. DiMarchi
Journal of Internal Medicine (2016) Vol. 281, Iss. 3, pp. 233-246
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Chrysoula Marogianni, Maria Sokratous, Efthimios Dardiotis, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8421-8421
Open Access | Times Cited: 266
FGF21 gene therapy as treatment for obesity and insulin resistance
Verónica Jiménez, Claudia Jambrina, Estefanía Casana, et al.
EMBO Molecular Medicine (2018) Vol. 10, Iss. 8
Open Access | Times Cited: 251
FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia
Tian Lan, Donald A. Morgan, Kamal Rahmouni, et al.
Cell Metabolism (2017) Vol. 26, Iss. 5, pp. 709-718.e3
Open Access | Times Cited: 216
FGF21 Signals Protein Status to the Brain and Adaptively Regulates Food Choice and Metabolism
Cristal M. Hill, Thomas Laeger, MADELEINE V. DEHNER, et al.
Cell Reports (2019) Vol. 27, Iss. 10, pp. 2934-2947.e3
Open Access | Times Cited: 184
Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis
Lucas D. BonDurant, Matthew J. Potthoff
Annual Review of Nutrition (2018) Vol. 38, Iss. 1, pp. 173-196
Open Access | Times Cited: 176
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
Stephen A. Harrison, Juan P. Frías, Guy Neff, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 12, pp. 1080-1093
Closed Access | Times Cited: 91
Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
Bhavna N. Desai, Garima Singhal, Mikiko Watanabe, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 11, pp. 1395-1406
Open Access | Times Cited: 126
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson’s Disease: Results from the EXosomes in PArkiNson’s Disease (EXPAND) Study
Anna Picca, Flora Guerra, Riccardo Calvani, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 504-504
Open Access | Times Cited: 115
A Common Allele in FGF21 Associated with Sugar Intake Is Associated with Body Shape, Lower Total Body-Fat Percentage, and Higher Blood Pressure
Timothy M. Frayling, Robin N. Beaumont, Samuel E. Jones, et al.
Cell Reports (2018) Vol. 23, Iss. 2, pp. 327-336
Open Access | Times Cited: 92
Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
Mohammad Zarei, Javier Pizarro‐Delgado, Emma Barroso, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 3, pp. 199-208
Open Access | Times Cited: 85
Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction
Yixuan Ma, Yixin Kuang, Wenyan Bo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12341-12341
Open Access | Times Cited: 85
A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway
Lichen Bao, Jun Yin, Wen Gao, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 16, pp. 3379-3393
Open Access | Times Cited: 84
Neuronal Mitochondrial Dysfunction Activates the Integrated Stress Response to Induce Fibroblast Growth Factor 21
Lisa Michelle Restelli, Björn Oettinghaus, Mark Halliday, et al.
Cell Reports (2018) Vol. 24, Iss. 6, pp. 1407-1414
Open Access | Times Cited: 84
The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol
Parkyong Song, Christoph Zechner, Genaro Hernandez, et al.
Cell Metabolism (2018) Vol. 27, Iss. 6, pp. 1338-1347.e4
Open Access | Times Cited: 83
FGF21 and the Physiological Regulation of Macronutrient Preference
Cristal M. Hill, Emily Qualls‐Creekmore, Hans‐Rudolf Berthoud, et al.
Endocrinology (2020) Vol. 161, Iss. 3
Open Access | Times Cited: 78
FGF21 promotes thermogenic gene expression as an autocrine factor in adipocytes
Mohammad Abu-Odeh, Yuan Zhang, Shannon M. Reilly, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109331-109331
Open Access | Times Cited: 75
Ketone Bodies in the Brain Beyond Fuel Metabolism: From Excitability to Gene Expression and Cell Signaling
Darío García-Rodríguez, Alfredo Giménez-Cassina
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 64
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study
Stephen A. Harrison, Juan P. Frías, Kathryn Jean Lucas, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 13
FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest
Susanna Søberg, Emilie S. Andersen, Niels B. Dalsgaard, et al.
Molecular Metabolism (2018) Vol. 11, pp. 96-103
Open Access | Times Cited: 76
Methionine restriction prevents onset of type 2 diabetes in NZO mice
Teresa Castaño-Martínez, Fabian Schumacher, Silke Schumacher, et al.
The FASEB Journal (2019) Vol. 33, Iss. 6, pp. 7092-7102
Open Access | Times Cited: 74
Mitochondrial uncoupling and longevity – A role for mitokines?
Susanne Klaus, Mario Ost
Experimental Gerontology (2019) Vol. 130, pp. 110796-110796
Closed Access | Times Cited: 74
FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia
Irini Manoli, Justin R. Sysol, Madeline Epping, et al.
JCI Insight (2018) Vol. 3, Iss. 23
Open Access | Times Cited: 73
Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?
Ai Guo, Kai Li, Qian Xiao
Experimental Gerontology (2020) Vol. 139, pp. 111022-111022
Closed Access | Times Cited: 58
Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia
Caslin A. Gilroy, Megan E. Capozzi, Anastasia Kristine Varanko, et al.
Science Advances (2020) Vol. 6, Iss. 35
Open Access | Times Cited: 56
Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets
Thao D. V. Le, Payam A. Fathi, Amanda B. Watters, et al.
Molecular Metabolism (2023) Vol. 72, pp. 101718-101718
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top